BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22823157)

  • 1. FDG-PET guided diagnosis of vaginal intravascular diffuse large B-cell lymphoma.
    Hemmaway CJ; Danga A; Igbokwe U; Radunovic A
    Br J Haematol; 2012 Sep; 158(6):678. PubMed ID: 22823157
    [No Abstract]   [Full Text] [Related]  

  • 2. 18F-Fluorodeoxyglucose positron emission tomography for evaluation of intravascular large B-cell lymphoma.
    Odawara J; Asada N; Aoki T; Yamakura M; Takeuchi M; Ohuchi T; Matsue K
    Br J Haematol; 2007 Mar; 136(5):684. PubMed ID: 17129231
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravascular large B-cell lymphoma diagnosed by FDG-PET/CT and endometrial biopsy.
    Takeoka Y; Inaba A; Fujitani Y; Kosaka S; Yamamura R; Senzaki H; Okamura T; Ohta K
    Rinsho Ketsueki; 2011 Nov; 52(11):1777-81. PubMed ID: 22185801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of FDG-PET to diagnose intravascular lymphomatosis presenting as fever of unknown origin.
    Hoshino A; Kawada E; Ukita T; Itoh K; Sakamoto H; Fujita K; Mantani N; Kogure T; Tamura J
    Am J Hematol; 2004 Jul; 76(3):236-9. PubMed ID: 15224358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG-PET/CT is a pivotal imaging modality to diagnose rare intravascular large B-cell lymphoma: case report and review of literature.
    Colavolpe C; Ebbo M; Trousse D; Khibri H; Franques J; Chetaille B; Coso D; Ouvrier MJ; Gastaud L; Guedj E; Schleinitz N
    Hematol Oncol; 2015 Jun; 33(2):99-109. PubMed ID: 24850057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early interim PET/CT predicts post-treatment response in diffuse large B-cell lymphoma.
    Wu X; Pertovaara H; Korkola P; Vornanen M; Järvenpää R; Dastidar P; Eskola H; Kellokumpu-Lehtinen PL
    Acta Oncol; 2014 Aug; 53(8):1093-9. PubMed ID: 24960581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive tonsillar enlargement with strong 18F-FDG uptake after chemotherapy for tonsillar diffuse large B-cell lymphoma.
    Hosokai R; Imai C; Takachi T; Yoshida S; Iwabuchi H; Imamura M; Uchiyama M
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):e87-8. PubMed ID: 21317812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of FDG-PET/CT for the diagnosis of intravascular large B-cell lymphoma presenting with fever of unknown origin and renal dysfunction].
    Yago K; Yanagita S; Aono M; Matsuo K; Shimada H
    Rinsho Ketsueki; 2009 Jun; 50(6):499-502. PubMed ID: 19571511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravascular large B-cell lymphoma with massive pulmonary lesions].
    Higashiyama A; Hashino S; Onozawa M; Takahata M; Okada K; Kahata K; Taniguchi N; Nasuhara Y; Kubota K; Fujimoto N; Matsuno Y; Nishimura M; Asaka M
    Rinsho Ketsueki; 2010 May; 51(5):353-6. PubMed ID: 20534958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated diffuse large B cell lymphoma of bone on PET scan.
    Chen WL; Ho CL
    Int J Hematol; 2008 Jul; 88(1):1-2. PubMed ID: 18478313
    [No Abstract]   [Full Text] [Related]  

  • 11. [Usefulness of FDG-PET in monitoring effects of the modality therapy for central nervous system malignant lymphoma: report of three cases].
    Masada T; Matsumoto Y; Kawai N; Tamiya T; Nagao S
    No Shinkei Geka; 2004 Aug; 32(8):859-64. PubMed ID: 15478653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resistance to first line chemotherapy treatment in a patient diagnosed of nodular lymphocyte-predominant Hodgkin's lymphoma identified by 18F-FDG PET/CT: diagnostic and therapeutic implications].
    Banzo J; Ubieto MA; Giraldo P; Razola P; Prats E; Tardin L; Santapau A; Parra A; Rambalde EF; Velilla J
    Rev Esp Med Nucl Imagen Mol; 2012; 31(2):89-92. PubMed ID: 21620527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.
    Martelli M; Ceriani L; Zucca E; Zinzani PL; Ferreri AJ; Vitolo U; Stelitano C; Brusamolino E; Cabras MG; Rigacci L; Balzarotti M; Salvi F; Montoto S; Lopez-Guillermo A; Finolezzi E; Pileri SA; Davies A; Cavalli F; Giovanella L; Johnson PW
    J Clin Oncol; 2014 Jun; 32(17):1769-75. PubMed ID: 24799481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse pulmonary uptake on FDG-PET with normal CT diagnosed as intravascular large B-cell lymphoma: a case report and a discussion of the causes of diffuse FDG uptake in the lungs.
    Wagner T; Brechemier D; Dugert E; Le Guellec S; Julian A; Hitzel A; Beyne-Rauzy O
    Cancer Imaging; 2012 Jan; 12(1):7-12. PubMed ID: 22275725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pure intravascular recurrence of CD5-positive diffuse large B-cell lymphoma primarily arising from the nasal cavities.
    Kano R; Masaie H; Hino A; Yasuoka H; Nagata S; Ishikawa J; Nakatsuka SI
    Diagn Pathol; 2018 Jul; 13(1):46. PubMed ID: 30041681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.
    Pardal E; Coronado M; Martín A; Grande C; Marín-Niebla A; Panizo C; Bello JL; Conde E; Hernández MT; Arranz R; Bargay J; González-Barca E; Pérez-Ceballos E; Montes-Moreno S; Caballero MD
    Br J Haematol; 2014 Nov; 167(3):327-36. PubMed ID: 25066542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravascular large B-cell lymphoma of the skin: typical clinical manifestations and a favourable response to rituximab-containing therapy.
    Feldmann R; Schierl M; Sittenthaler M; Jahn R; Wogritsch C; Cerroni L; Steiner A; Breier F
    Dermatology; 2009; 219(4):344-6. PubMed ID: 19590171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A neurological presentation of intravascular B-cell lymphoma.
    Kendall KM; Thomas RH; Corkill RG; Robertson NP
    BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22865806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma.
    Avigdor A; Sirotkin T; Kedmi M; Ribakovsy E; Berkowicz M; Davidovitz Y; Kneller A; Merkel D; Volchek Y; Davidson T; Goshen E; Apter S; Shimoni A; Ben-Bassat I; Nagler A
    Ann Hematol; 2014 Aug; 93(8):1297-304. PubMed ID: 24595734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of FDG-PET to diagnose intravascular lymphoma with encephalopathy and renal involvement.
    Balkema C; Meersseman W; Hermans G; Stroobants S; Verhoef G; Verbeken E; Demaerel P; Blockmans D
    Acta Clin Belg; 2008; 63(3):185-9. PubMed ID: 18714849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.